Design and reporting of prebiotic and probiotic clinical trials in the context of diet and the gut microbiome - Université de Lorraine
Article Dans Une Revue Nature Microbiology Année : 2024

Design and reporting of prebiotic and probiotic clinical trials in the context of diet and the gut microbiome

Résumé

Diet is a major determinant of the gastrointestinal microbiome composition and function, yet our understanding of how it impacts the efficacy of prebiotics and probiotics is limited. Here we examine current evidence of dietary influence on prebiotic and probiotic efficacy in human studies, including potential mechanisms. We propose that habitual diet be included as a variable in prebiotic and probiotic intervention studies. This recommendation is based on the potential mechanisms via which diet can affect study outcomes, either directly or through the gut microbiome. We consider the challenges and opportunities of dietary assessment in this context. Lastly, we provide recommendations for the design, conduct and reporting of human clinical trials of prebiotics and probiotics (and other biotic interventions) to account for any effect of diet and nutrition.
Fichier non déposé

Dates et versions

hal-04765847 , version 1 (04-11-2024)

Identifiants

Citer

Kevin Whelan, Margaret Alexander, Claire Gaiani, Genelle Lunken, Andrew Holmes, et al.. Design and reporting of prebiotic and probiotic clinical trials in the context of diet and the gut microbiome. Nature Microbiology, 2024, 9 (11), pp.2785-2794. ⟨10.1038/s41564-024-01831-6⟩. ⟨hal-04765847⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More